(EMAILWIRE.COM, July 06, 2018 ) The home healthcare market is expected to reach USD 364.69 billion by 2022 from USD 239.30 billion in 2017, growing at a CAGR of 8.8%.

Full Report : https://www.marketsandmarkets.com/Market-Reports/home-healthcare-equipment-market-696.html

Growth in this market is mainly driven by the growing geriatric population; increasing incidence of chronic diseases; and rising demand for affordable healthcare delivery systems due to increasing healthcare cost, technological advancements, and government initiatives to promote home healthcare.

Product launches and approvals accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Roche, Philips Healthcare, Omron, GE Healthcare, McKesson, Fresenius, A&D, BAYADA Home Healthcare, and Abbott Laboratories.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=696

The home healthcare market is highly fragmented, with several big as well as emerging players. In addition, each product segment has a different set of key vendors. Prominent players in this market include Philips Healthcare (Netherlands), Kindred Healthcare (US), Linde Group (Germany), Almost Family (US), Abbott Laboratories (US), LHC Group (US), A&D (Japan), Amedisys (US), Fresenius (Germany), Omron (Japan), McKesson (US), BAYADA Home Healthcare (US), Kinnser Software, (US), and Roche (Switzerland).

Fresenius is one of the leading players in the home healthcare market. It offers a wide range of products and services in the home healthcare market, including dialysis products and services for patients with chronic kidney failure. The company focuses on innovation to provide safe and cost-effective products. It also concentrates on organic as well as inorganic strategies such as product launches, expansions, and acquisitions to strengthen its market position. In the past three years, Fresenius has acquired five companies to increase its presence in the market and expand its product portfolio. In 2017, Fresenius Medical Care acquired NxStage Medical (US) and Cura Group (Australia). Such strategic developments help the company maintain its leading position in the home healthcare market.

Read Official Press Release : https://www.prnewswire.com/news-releases/home-healthcare-market-worth-36469-billion-usd-by-2022-657216163.html

GE Healthcare has a strong geographic presence and robust product portfolio. The company offers transformational medical technologies and services to meet the demand for increased access, enhanced quality, and more affordable healthcare around the world. The company focuses on launching new products. For instance, in August 2016, the company launched Vivid iq, a new generation of high-end, portable, and compact cardiovascular ultrasound which can be used in remote locations. Such developments help the company to leverage growth opportunities in the home healthcare market. GE Healthcare also has a strong sales and distribution network that allows it to market its products across the globe efficiently.